ABD - İngilizce - NLM (National Library of Medicine)

blenheim pharmacal, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine - unii:q830pw7520) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the relief of mild to moderately severe pain. this product should not be administered to patients who have previously exhibited hypersensitivity to codeine or acetaminophen. acetaminophen and codeine phosphate tablets are classified as a schedule iii controlled substance. codeine can produce drug dependence of the morphine type and, therefore, has the potential for being abused. psychological dependence, physical dependence, and tolerance may develop upon repeated administration and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral narcotic medications.

ABD - İngilizce - NLM (National Library of Medicine)

rebel distributors corp. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine - unii:q830pw7520) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the relief of mild to moderately severe pain. this product should not be administered to patients who have previously exhibited hypersensitivity to codeine or acetaminophen. acetaminophen and codeine phosphate tablets are classified as a schedule iii controlled substance. codeine can produce drug dependence of the morphine type and, therefore, has the potential for being abused. psychological dependence, physical dependence, and tolerance may develop upon repeated administration and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral narcotic medications.

ABD - İngilizce - NLM (National Library of Medicine)

mylan institutional llc - magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838) - magnesium chloride 200 mg in 1 ml - as an electrolyte replenisher in magnesium deficiencies. magnesium chloride injection should not be administered if there is renal impairment, marked myocardial disease or to comatose patients.

ABD - İngilizce - NLM (National Library of Medicine)

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

ABD - İngilizce - NLM (National Library of Medicine)

bryant ranch prepack - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] •have not provided adequate analgesia, or are not expected to provide adequate analgesia •have not been tolerated, or are not expected to be tolerated acetaminophen and codeine phosphate tablets are contraindicated for: - all children younger than 12 years of age (see warnings ). - post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy (see warnings ).  acetaminophen and codeine phosphate tablets are contraindicated in patients with:  - significant respiratory depression [seewarnings ]. -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - taurine, quantity: 73.33 mg/g; potassium citrate, quantity: 22.099 mg/g (equivalent: potassium, qty 8 mg/g); magnesium amino acid chelate, quantity: 13.333 mg/g (equivalent: magnesium, qty 1.333 mg/g); pyridoxal 5-phosphate, quantity: 2.665 mg/g (equivalent: pyridoxine, qty 1.824 mg/g); selenomethionine, quantity: 8.67 microgram/g (equivalent: selenium, qty 3.47 microgram/g); chromium picolinate, quantity: 54 microgram/g (equivalent: chromium, qty 6.7 microgram/g); magnesium aspartate dihydrate, quantity: 7.12 mg/g (equivalent: magnesium, qty 534 microgram/g); glutamine, quantity: 66.67 mg/g; zinc amino acid chelate, quantity: 4 mg/g (equivalent: zinc, qty 800 microgram/g); calcium ascorbate dihydrate, quantity: 16.231 mg/g (equivalent: ascorbic acid, qty 13.334 mg/g); magnesium citrate, quantity: 186.25 mg/g (equivalent: magnesium, qty 29.8 mg/g); magnesium amino acid chelate, quantity: 100 mg/g (equivalent: magnesium, qty 10 mg/g); calcium folinate, quantity: 28 microgram/g (equivalent: folinic acid, qty 20 microgram/g); thiamine nitrate, quantity: 4.11 mg/g (equivalent: thiamine, qty 3.33 mg/g); cyanocobalamin, quantity: 6.67 microgram/g; nicotinamide, quantity: 2.67 mg/g; pyridoxine hydrochloride, quantity: 5.885 mg/g (equivalent: pyridoxine, qty 4.842 mg/g); ascorbic acid, quantity: 20 mg/g; magnesium orotate dihydrate, quantity: 15.152 mg/g (equivalent: magnesium, qty 1 mg/g) - powder, oral - excipient ingredients: stevia rebaudiana; thaumatin; colloidal anhydrous silica; inulin; calcium hydrogen phosphate dihydrate; malic acid; xanthan gum; citric acid; beetroot; maltodextrin; ascorbic acid; raspberry; silicon dioxide; blackberry; hippophae rhamnoides; beta vulgaris; pomegranate; salvia hispanica; black currant; malpighia glabra; strawberry; sambucus nigra; vaccinium myrtillus; cranberry; tapioca starch; flavour - helps convert (state food) into energy ; maintain/support energy production ; maintain/support general health and wellbeing ; maintain/support healthy cardiovascular system function ; maintain/support healthy muscle contraction function ; maintain/support muscle health ; maintain/support muscle function ; maintain/support healthy neuromuscular system/function ; maintain/support muscle relaxation ; maintain/support muscle tone ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support (state vitamin/mineral) within normal range ; maintain/support nerve conduction ; aid/assist/helps synthesis of neurotransmitters

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

hivita happy energy pty ltd - nicotinamide, quantity: 350 mg; magnesium amino acid chelate, quantity: 50 mg (equivalent: magnesium, qty 10 mg); manganese amino acid chelate, quantity: 55 mg (equivalent: manganese, qty 5.5 mg); zinc amino acid chelate, quantity: 40 mg (equivalent: zinc, qty 8 mg); calcium amino acid chelate, quantity: 10 mg (equivalent: calcium, qty 2 mg); calcium pantothenate, quantity: 20 mg (equivalent: calcium, qty 1.68 mg; equivalent: pantothenic acid, qty 18.32 mg); colecalciferol, quantity: 0.005 mg; d-alpha-tocopheryl acid succinate, quantity: 15 mg; ascorbic acid, quantity: 200 mg; lysine hydrochloride, quantity: 10 mg; thiamine hydrochloride, quantity: 100 mg (equivalent: thiamine, qty 89.18 mg); pyridoxine hydrochloride, quantity: 50 mg (equivalent: pyridoxine, qty 41.14 mg); biotin, quantity: 30 microgram; cyanocobalamin, quantity: 25 microgram; folic acid, quantity: 400 microgram; choline bitartrate, quantity: 50 mg; inositol, quantity: 25 mg; nicotinic acid, quantity: 35 mg; selenomethionine, quantity: 248 microgram (equivalent: selenium, qty 100 microgram); calcium hydrogen phosphate dihydrate, quantity: 20 mg (equivalent: calcium, qty 4.65 mg); glutamine, quantity: 25 mg; riboflavin, quantity: 15 mg; retinol acetate, quantity: 0.2587 mg; potassium aspartate, quantity: 10.47 mg (equivalent: potassium, qty 2.2 mg) - tablet, enteric coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; iron oxide red; cellacefate; silicon dioxide; hypromellose; betaine hydrochloride; povidone; vanillin; carnauba wax; soy polysaccharide; ethylcellulose; magnesium stearate; triacetin; maize starch; gelatin; butylated hydroxytoluene; sucrose; dl-alpha-tocopherol; hydrolysed gelatin; hydrogenated soya oil - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; enhance/promote energy levels ; maintain/support energy levels ; helps enhance/promote body energy reserves ; maintain/support healthy eyesight/vision ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; helps maintain/support vasodilator/ blood vessel dilation ; maintain/support blood vessel health ; helps enhance/promote blood vessel health ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; aids/assists the body to cope with environmental stress ; support healthy body stress recovery ; support healthy stress response in the body ; decrease/reduce/relieve nervous tension/unrest ; decrease/reduce/relieve symptoms of mild anxiety ; helps reduce occurrence of symptoms of mild anxiety ; aid/assist/helps synthesis of neurotransmitters ; support healthy emotional/mood balance

ABD - İngilizce - NLM (National Library of Medicine)

epm packaging inc - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - codeine-containing products are contraindicated for postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy. this product should not be administered to patients who have previously exhibited hypersensitivity to codeine or acetaminophen.

ABD - İngilizce - NLM (National Library of Medicine)

stat rx usa llc - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), butalbital (unii: khs0az4jvk) (butalbital - unii:khs0az4jvk), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - acetaminophen 325 mg - butalbital, acetaminophen and caffeine tablets are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. caution in this regard is required because butalbital is habit-forming and potentially abusable. this product is contraindicated under the following conditions: - hypersensitivity or intolerance to any component of this product. - patients with porphyria. abuse and dependence: butalbital: barbiturates may be habit-forming: tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. the average daily dose for the barbiturate addict is usually about 1500 mg. as tolerance to barbiturates develops, the amount needed to maintain the same level of intoxication increases; tolerance to a fatal dosage, however, does not increase more than two-fold. as thi

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 2mmol/ml) solution for injection 10ml ampoules (martindale pharmaceuticals ltd - magnesium sulfate heptahydrate - solution for injection - 500mg/1ml